Literature DB >> 10619825

Antigen inhalation unmasks NK-2 tachykinin receptor-mediated responses in vagal afferents.

K A Moore1, B J Undem, D Weinreich.   

Abstract

The majority of airway sensory innervation originates from afferent neurons whose somata reside in vagal (nodose and jugular) ganglia. Using guinea pigs immunized with chick ovalbumin, we have discovered that airway inflammation provokes phenotypic changes in the tachykinin responsiveness of nodose neurons. Bath application of substance P (SP; 0.1 to 10 microM) to nodose neurons isolated from guinea pigs with normal uninflamed airways did not elicit measurable changes in resting electrophysiological properties. In sharp contrast, 80% of nodose neurons isolated 24 h after in vivo aerosolized antigen challenge of the airway were depolarized by 100 nM SP. Inhalation of a nonantigenic protein did not evoke the expression of SP responses. Pharmacological analysis revealed that SP responses unmasked by airway inflammation were mediated by neurokinin-2 (NK-2) tachykinin receptors. There are several potential mechanisms for transduction of an "unmasking signal" from the inflamed airway to vagal afferent somata. The vagus nerve may relay the signal, either through anterograde transport and/or nerve impulse activity. Alternatively, a signal generated by airway inflammation may be carried by the circulation to the nodose ganglia. Unilateral vagotomy significantly reduced the percentage of SP-responsive neurons compared with intact controls, suggesting that the vagus nerve is required for unmasking of NK-2 responses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10619825     DOI: 10.1164/ajrccm.161.1.9903091

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  16 in total

Review 1.  Experimental models and mechanisms of enhanced coughing.

Authors:  Donald C Bolser
Journal:  Pulm Pharmacol Ther       Date:  2004       Impact factor: 3.410

Review 2.  Cough as an adverse effect on inhalation pharmaceutical products.

Authors:  Rachel Yoon Kyung Chang; Philip Chi Lip Kwok; Sussan Ghassabian; John D Brannan; Heikki O Koskela; Hak-Kim Chan
Journal:  Br J Pharmacol       Date:  2020-08-07       Impact factor: 8.739

3.  Three days after a single exposure to ozone, the mechanism of airway hyperreactivity is dependent on substance P and nerve growth factor.

Authors:  Kirsten C Verhein; Mehdi S Hazari; Bart C Moulton; Isabella W Jacoby; David B Jacoby; Allison D Fryer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-05       Impact factor: 5.464

Review 4.  Vagal Afferent Innervation of the Airways in Health and Disease.

Authors:  Stuart B Mazzone; Bradley J Undem
Journal:  Physiol Rev       Date:  2016-07       Impact factor: 37.312

Review 5.  Inhibitory neurotransmission regulates vagal efferent activity and gastric motility.

Authors:  Caitlin A McMenamin; R Alberto Travagli; Kirsteen N Browning
Journal:  Exp Biol Med (Maywood)       Date:  2016-06

6.  Exposure to a high fat diet during the perinatal period alters vagal motoneurone excitability, even in the absence of obesity.

Authors:  Ruchi Bhagat; Samuel R Fortna; Kirsteen N Browning
Journal:  J Physiol       Date:  2014-12-02       Impact factor: 5.182

7.  Roux-en-Y gastric bypass reverses the effects of diet-induced obesity to inhibit the responsiveness of central vagal motoneurones.

Authors:  Kirsteen N Browning; Samuel R Fortna; Andras Hajnal
Journal:  J Physiol       Date:  2013-03-04       Impact factor: 5.182

Review 8.  TRPV1 antagonists as potential antitussive agents.

Authors:  Robbie L McLeod; Craig C Correll; Yanlin Jia; John C Anthes
Journal:  Lung       Date:  2007-10-10       Impact factor: 2.584

Review 9.  Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.

Authors:  Alessandro Lecci; Angela Capriati; Carlo Alberto Maggi
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

10.  Molecular signaling and targets from itch: lessons for cough.

Authors:  Pamela Colleen Lavinka; Xingzhong Dong
Journal:  Cough       Date:  2013-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.